QuakerSmith Capital helps scientists, inventors, and entrepreneurs develop and commercialize novel therapeutic agents, medical devices, diagnostics, and life sciences related technologies. The company advises, supports, and funds new ventures in the early stages of development, often before company formation or business plan development.
QuakerSmith Capital focuses on helping inventors and research teams identify and demonstrate the true commercial potential of their promising new discoveries or emerging technologies. We also help develop strategies and plans to optimize realizable value, secure the necessary funding and human resources, and manage execution all the way through to successful value capture.
QuakerSmith Capital has worked with a number of innovators and ventures since its founding in 2003.